Genetic lineages of undifferentiated-type gastric carcinomas analysed by unsupervised clustering of genomic DNA microarray data

BMC Medical Genomics

Volumn 6, Issue 1, 2013, Pages

  Sonoda, Ayano ^a   Mukaisho, Ken Ichi ^a   Nakayama, Takahisa ^a   Diem, Vo Thi Ngoc ^a   Hattori, Takanori ^a   Andoh, Akira ^a   Fujiyama, Yoshihide ^a   Sugihara, Hiroyuki ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; GENOMIC DNA; MYC PROTEIN; NEUROFIBROMIN; PROTEIN P53; RAN PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE;

ADENOMATOUS POLYPOSIS COLI GENE; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; EPH RECEPTOR A10 GENE; EPH RECEPTOR A5 GENE; EPH RECEPTOR A7 GENE; EPH RECEPTOR B2 GENE; ETS VARIANT 6 GENE; FEMALE; GENE CLUSTER; GENE DOSAGE; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE LOSS; GENETIC ASSOCIATION; GENETIC GAIN; GENETIC LINKAGE; GENETIC MARKER; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; LAYERED STRUCTURE UNDIFFERENTIATED GASTRIC CARCINOMA; MALE; MULTIPLE ENDOCRINE NEOPLASIA 1 GENE; NEUROFIBROMIN 1 GENE; ONCOGENE; ONCOGENE C KIT; ONCOGENE C MYC; PRIORITY JOURNAL; RAB37 GENE; RAB39B GENE; RAB9A GENE; RAN GENE; SIGNET RING CARCINOMA; SPLEEN FOCUS FORMING VIRUS PROVIRAL INTEGRATION ONCOGENE; STOMACH CARCINOMA; TELOMERASE REVERSE TRANSCRIPTASE GENE; TRIO RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR GENE; TUBULAR COMPONENT UNDIFFERENTIATED GASTRIC CARCINOMA; TUMOR SUPPRESSOR GENE; UNDIFFERENTIATED GASTRIC CARCINOMA; V ETSERYTHROBLASTOSIS VIRUS E26 ONCOGENE HOMOLOG 1 GENE;

AGED; CARCINOMA; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; FEMALE; GENETIC LINKAGE; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-MYC; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880334150     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-6-25     Document Type: Article

References (39)

1. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Lauren P, Acta Pathol Microbiol Scand 1965 64 31 49 14320675
2. Classification of gastric carcinomas. Carneiro F, Curr Diagn Pathol 1997 4 51 59 10.1016/S0968-6053(97)80008-7 (Pubitemid 127819220)
3. Japanese classification of gastric carcinoma: 3rd English edition. Japanese Gastric Cancer Association, Gastric Cancer 2011 14 101 112 21573743
4. The common 18-base pair deletion at codons 418-423 of the E-cadherin gene in differentiated-type adenocarcinomas and intramucosal pre cancerous lesions of the stomach with the features of gastric foveolar epithelium. Endoh Y, Tamura G, Watanabe H, Ajioka Y, Motoyama T, J Pathol 1999 189 201 206 10.1002/(SICI)1096-9896(199910)189:2<201::AID-PATH409>3.0.CO;2-A 10547575 (Pubitemid 29448913)
5. Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Saito A, Shimoda T, Nakanishi Y, Ochiai A, Toda G, Pathol Int 2001 51 165 171 10.1046/j.1440-1827.2001.01179.x 11328531 (Pubitemid 32337065)
6. Characterization of Signet Ring Cell Carcinoma of the Stomach. Otsuji E, Yamaguchi T, Sawai K, Takahashi T, J Surg Oncol 1998 67 216 220 10.1002/(SICI)1096-9098(199804)67:4<216::AID-JSO2>3.0.CO;2-B 9579367 (Pubitemid 28196910)
7. Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group. Sawada T, Nakata T, Takasugi N, Maeda K, Hanawa Y, Shimizu K, Hirayama M, Takeda T, Mori T, Koide R, Tsunoda A, Nagahara N, Yamamoto K, Lancet 1984 2 271 273 6146820 (Pubitemid 14057087)
8. Number and cure rate of neuroblastoma cases detected by the mass screening program in Japan: future aspects. Sawada T, Sugimoto T, Tanaka T, Kawakatsu H, Ishii T, Matsumura T, Horii Y, Med Pediatr Oncol 1987 15 14 17 10.1002/mpo.2950150104 3561327
9. Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening. Murphy SB, Cohn SL, Craft AW, Woods WG, Sawada T, Castleberry RP, Levy HL, Prorok PC, Hammond GD, Lancet 1991 337 344 346 10.1016/0140-6736(91)90957-Q 1671243
10. Different karyotypic patterns in early and advanced stage neuroblastomas. Kaneko Y, Kanda N, Maseki N, Sakurai M, Tsuchida Y, Takeda T, Okabe I, Sakurai M, Cancer Res 1987 47 311 318 3791218 (Pubitemid 17002142)
11. Biology of neuroblastomas that were found by mass screening at 6 months of age in Japan. Kaneko Y, Kobayashi H, Watanabe N, Tomioka N, Nakagawara A, Pediatr Blood Cancer 2006 46 285 291 10.1002/pbc.20496 16078225 (Pubitemid 43201842)
12. Morphology and modes of cell proliferation in earliest signet ring cell carcinomas induced in canine stomachs by N-ethyl-N'-nitro-N-nitrosoguanidine. Sugihara H, Hattori T, Imamura Y, Noriki S, Fukuda M, Katsura K, Tsuchihashi Y, Fujita S, J Cancer Res Clin Oncol 1991 117 197 204 10.1007/BF01625425 1851763
13. Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach. Sugihara H, Hattori T, Fukuda M, Fujita S, Virchows Arch A 1987 411 117 127 10.1007/BF00712735 (Pubitemid 17086444)
14. Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours. Peng DF, Sugihara H, Mukaisho K, Tsubosa Y, Hattori T, J Pathol 2003 201 439 450 10.1002/path.1459 14595756 (Pubitemid 37408265)
15. Genetic lineage of poorly differentiated gastric carcinoma with a tubular component analysed by comparative genomic hybridization. Peng DF, Sugihara H, Mukaisho K, Ling ZQ, Hattori T, J Pathol 2004 203 884 895 10.1002/path.1586 15258990 (Pubitemid 39089276)
16. Lineageeanalysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous? Nakayama T, Ling ZQ, Mukaisho K, Hattori T, Sugihara H, BMC Cancer 2010 10 311 321 10.1186/1471-2407-10-311 20565940
17. Intratumoural heterogeneity of intestinal expression reflects environmental induction and progression-related loss of induction in undifferentiated-type gastric carcinomas. Natsagdorj L, Sugihara H, Bamba M, Hattori T, Histopathology 2008 53 685 697 10.1111/j.1365-2559.2008.03166.x 19102008 (Pubitemid 352768715)
18. Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA. Little SE, Vuononvirta R, Reis-Filho JS, Natrajan R, Iravani M, Fenwick K, Mackay A, Ashworth A, Pritchard-Jones K, Jones C, Genomics 2006 87 298 306 10.1016/j.ygeno.2005.09.019 16271290 (Pubitemid 43117451)
19. Changes in DNA copy number in primary gastric carcinomas by comparative genomic hybridization. Koizumi Y, Tanaka S, Mou R, Koganei H, Kokawa A, Kitamura R, Yamauchi H, Ookubo K, Saito T, Tominaga S, Matsumura K, Shimada H, Tsuchida N, Sekihara H, Clin Cancer Res 1997 3 1067 1076 9815785 (Pubitemid 27319752)
20. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Sakakura C, Mori T, Sakabe T, Ariyama Y, Shinomiya T, Date K, Hagiwara A, Yamaguchi T, Takahashi T, Nakamura Y, Abe T, Inazawa J, Genes Chromosomes Cancer 1999 24 299 305 10.1002/(SICI)1098-2264(199904)24:4<299::AID-GCC2>3.0.CO;2-U 10092127 (Pubitemid 29115867)
21. Helicobacter pylori-related and -non-related gastric cancers do not differ with respect to chromosomal aberrations. van Grieken NC, Weiss MM, Meijer GA, Hermsen MA, Scholte GH, Lindeman J, Craanen ME, Bloemena E, Meuwissen SG, Baak JP, Kuipers EJ, J Pathol 2000 192 301 306 10.1002/1096-9896(2000)9999: 9999<::AID-PATH697>3.0.CO;2-F 11054712
22. Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression. Kimura Y, Noguchi T, Kawahara K, Kashima K, Daa T, Yokoyama S, Mod Pathol 2004 17 1328 1337 10.1038/modpathol.3800180 15154013 (Pubitemid 39472987)
23. Frequent gains of 20q and losses of 18q are associated with lymph node metastasis in intestinal-type gastric cancer. Hidaka S, Yasutake T, Kondo M, Takeshita H, Yano H, Haseba M, Tsuji T, Sawai T, Nakagoe T, Tagawa Y, Anticancer Res 2003 23 3353 3357 12926075 (Pubitemid 36975435)
24. Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization. Takada H, Imoto I, Tsuda H, Sonoda I, Ichikura T, Mochizuki H, Okanoue T, Inazawa J, Cancer Sci 2005 96 100 110 10.1111/j.1349-7006.2005.00016.x 15723654 (Pubitemid 40425385)
25. Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer. Yang S, Jeung HC, Jeong HJ, Choi YH, Kim JE, Jung JJ, Rha SY, Yang WI, Chung HC, Genomics 2007 89 451 459 10.1016/j.ygeno.2006.12.001 17229543 (Pubitemid 46413666)
26. Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer. Fan B, Dachrut S, Coral H, Yuen ST, Chu KM, Law S, Zhang L, Ji J, Leung SY, Chen X, PLoS One 2012 7 29824 10.1371/journal.pone.0029824 22539939
27. Correlation between genomic alterations assessed by array comparative genomic hybridization, prognostically informative histologic subtype, stage, and patient survival in gastric cancer. Rossi E, Klersy C, Manca R, Zuffardi O, Solcia E, Hum Pathol 2011 42 1937 1945 10.1016/j.humpath.2011.02.016 21676433
28. Ski and SnoN, potent negative regulators of TGF-beta signaling. Deheuninck J, Luo K, Cell Res 2009 19 47 57 10.1038/cr.2008.324 19114989
29. SnoN in mammalian development, function and diseases. Jahchan NS, Luo K, Curr Opin Pharmacol 2010 10 6 670 675 10.1016/j.coph.2010.08.006 20822955
30. Expression Profiles of SnoN in Normal and Cancerous Human Tissues Support Its Tumor Suppressor Role in Human Cancer. Jahchan NS, Ouyang G, Luo K, PLoS One 2013 8 2 55794 10.1371/journal.pone.0055794 23418461
31. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Heinrich MC, Rubin BP, Longley BJ, Fletcher JA, Hum Pathol 2002 33 484 495 10.1053/hupa.2002.124124 12094373 (Pubitemid 34747867)
32. The Emerging Role of the RAB25 Small GTPase in Cancer. Agarwal R, Jurisica I, Mills GB, Cheng KW, Traffic 2009 10 11 1561 1568 10.1111/j.1600-0854.2009.00969.x 19719478
33. Protein composition of catalytically active human telomerase from immortal cells. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR, Science 2007 315 1850 1853 10.1126/science.1138596 17395830 (Pubitemid 46580145)
34. Telomere maintenance mechanisms and cellular immortalization. Colgin LM, Reddel RR, Curr Opin Genet Dev 1999 9 97 103 10.1016/S0959-437X(99)80014-8 10072358 (Pubitemid 29080393)
35. Conditional telomerase induction causes proliferation of hair follicle stem cells. Sarin KY, Cheung P, Gilison D, Lee E, Tennen RI, Wang E, Artandi MK, Oro AE, Artandi SE, Nature 2005 436 1048 1052 10.1038/nature03836 16107853 (Pubitemid 41191691)
36. The Biology of the Ets1 Proto-Oncogene. Jürgen D, Mol Cancer 2003 2 29 10.1186/1476-4598-2-29 12971829 (Pubitemid 38751468)
37. Eph receptors and ephrins in cancer: bidirectional signaling and Beyond. Pasquale EB, Nat Rev Cancer 2010 10 3 165 180 10.1038/nrc2806 20179713
38. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Humar B, Guilford P, Cancer Sci 2009 100 1151 1157 10.1111/j.1349-7006.2009. 01163.x 19432899
39. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers. Dumont N, Wilson MB, Crawford YG, Reynolds PA, Sigaroudinia M, Tlsty TD, Proc Natl Acad Sci USA 2008 105 14867 14872 10.1073/pnas.0807146105 18806226